Form 8-K - Current report:
SEC Accession No. 0001615774-16-003871
Filing Date
2016-01-12
Accepted
2016-01-12 09:00:30
Documents
1
Period of Report
2016-01-12
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT s102469_8k.htm 8-K 14364
  Complete submission text file 0001615774-16-003871.txt   15638
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

EIN.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24006 | Film No.: 161337719
SIC: 2834 Pharmaceutical Preparations